ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Spondylarthropathies"

  • Abstract Number: 0543 • ACR Convergence 2020

    Exercise Among Older Adults Living with Rheumatic Disease: Physical Activity Habits and Patient Reported Outcomes

    Alexis Ogdie1, Sofia Pedro2, Joshua Baker3, Kaleb Michaud4 and Patricia Katz5, 1University of Pennsylvania, Philadelphia, PA, 2FORWARD-The National Data Bank for Rheumatic Diseases, Wichita, 3Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, 4FORWARD-The National Data Bank for Rheumatic Diseases; University of Nebraska Medical Center, Wichita, 5University of California, San Francisco, Novato, CA

    Background/Purpose: Among patients with rheumatic disease, physical activity is important for maintaining health and improving outcomes.  EULAR recommendations suggest at least 30 min of vigorous…
  • Abstract Number: 1342 • ACR Convergence 2020

    Efficacy Outcomes Following Etanercept Withdrawal by Sustained Remission Status in Patients with Nr-axSpA: Results from RE-EMBARK

    Filip Van den Bosch1, Peter Nash2, James Cheng-Chung Wei3, Francisco Blanco4, Vassilis Tsekouras5, Chuanbo Zang6, Daniela Graham7, Edmund Arthur8, Pamela Selema6, Bonnie Vlahos6 and Atul Deodhar9, 1Ghent University Hospital, Ghent, Belgium, 2School of Medicine Griffith University, Brisbane, Queensland, Australia, 3Chung Shan Medical University Hospital, Taichung, Taiwan (Republic of China), 4INIBIC-Complejo Hospitalario Universitario A Coruña, A Coruna, Spain, 5Pfizer, Nicosia, Cyprus, 6Pfizer, Collegeville, PA, 7Pfizer, Groton, PA, 8Pfizer, Peapack, NJ, 9Oregon Health & Science University, Portland, OR

    Background/Purpose: Etanercept (ETN) is effective and well tolerated in patients with non-radiographic axial spondyloarthritis (nr-axSpA). However, there is limited information on the effects of withdrawing…
  • Abstract Number: 1887 • ACR Convergence 2020

    Spinal Mobility and Function: How Closely Do They Associate in Axial Spondyloarthropathy?

    Sinead Maguire1, Phil Gallagher2 and Finbar O'Shea1, 1St James' Hospital, Dublin, Ireland, 2St Vincents University Hospital, UCD, Dublin, Ireland

    Background/Purpose: Axial spondyloarthropathy (axSpA) is a form of inflammatory arthritis affecting the axial skeleton. Persistent disease activity can result in restricted spinal mobility over time,…
  • Abstract Number: 0548 • ACR Convergence 2020

    Incidence of First Cardiovascular Event in Spanish Patients with Chronic Inflammatory Rheumatic Diseases. Prospective Data After Five Years of Follow Up

    Maria Auxiliadora Martin-Martinez1, Santos Castañeda2, Fernando Sanchez-Alonso3, Carmen García-Gómez4, Carlos González_Juanatey5, M. Ángeles Belmonte-López6, Jesus Tornero-Molina7, José Santos-Rey8, Carmen Olga Sánchez-González9, Estefania Moreno10, Maria del puerto Moreno-Gil11, Tatiana Cobo-Ibañez12, Jose Antonio Pinto-Tasende13, Jesús Babío-Herráez14, Gema Bonilla15, Antonio Juan-Mas16, Francisco Manero-Ruiz17, Montserrat Romera-Baurés18, Javier Bachiller-Corral19, Eugenio Chamizo-Carmona20, Javier Calvo-Catalán21, Raimon Sanmartí22, Celia Erausquin-Arruabarrena23, Rosario Garcia-Vicuña24, Carmen Barbadillo25, Sergio Ros-Expósito26, Ana Isabel Turrión27, M José González-Fernández28, Jose Miguel Senabre29, Silvia Martínez-Pardo30, Ana Ruibal-Escribano31, Emilio Giner-Serret32, Elisabet Berzosa-Sola33, Julia Martínez-Barrio34, Encarnación Pagán35, M Enriqueta- Peiró36, Sagrario Bustabad-Reyes37, Alba Erra-Durán38, Beatriz González Álvarez39, Ana Cruz Valenciano40, Javier Rivera-Redondo41, Manuel Moreno Ramos42, Sergio Rodriguez Montero43, Mercedes Morcillo-Valle44, Maria Teresa Navío45, Maria Galindo-Izquierdo46, Manuel Riera-Soler47, Jordi Fiter48, Javier Llorca49 and Miguel Ángel González-Gay50, 1Spanish Society of Rheumatology, Madrid, Spain, 2Princesa University Hospital, Universidad Autónoma, Madrid, Madrid, Spain, 3Biobadaser, Research Unit, Sociedad Española de Reumatología, Madrid, Spain, 4Consorci Sanitari de Terrassa, Barcelona, Spain, 5Hospital Lucus Augusti, Lugo, Spain, 6Hospital Regional Universitario Carlos Haya, Malaga, Spain, 7University Hospital of Guadalajara. Spain, Madrid, Madrid, Spain, 8Hospital Virgen de la Salud, Toledo, Spain, 9Hospital Sureste, Madrid, Spain, 10Universitario Vall D'hebron, Barcelona, Spain, 11Complejo Hospitalario de Cáceres, Caceres, Spain, 12Hospital Infanta Sofia, Madrid, Spain, 13CHUAC, A Coruña, Spain, 14Hospital de Cabueñes, Gijón, Spain, 15Rheumatology, La Paz University Hospital-IdiPAZ, Madrid, Spain, 16Hospital Sont Llatzer, Palma de Mallorca, Spain, 17Hospital Universitario Miguel Servet, Zaragoza, Spain, 18Hospital Universitario de Bellvitge, Barcelona, Spain, 19Rheumatology, Hospital Universitario Ramón y Cajal, Madrid, Spain, 20Hospital de Merida, Badajoz, Spain, 21Hospital General Universitario Valencia, Valencia, Spain, 22Hospital Universitari Clínic de Barcelona, Barcelona, Catalonia, Spain, 23Hospital de Gran Canaria Dr. Negrín, Gran Canaria, Spain, 24Hospital Universitario de la Princesa, IIS-Princesa, UAM, Madrid, Madrid, Spain, 25Hospital Universitario Puerta de Hierro, Madrid, Spain, 26Hospital Viladecans, Barcelona, Spain, 27Hospital Universitario de Salamanca, Salamanca, Spain, 28Hospital Dexeus, Barcelona, Spain, 29Hospital de Marina Baixa, Alicante, Spain, 30H. Mutua de Terrassa, Barcelona, Catalonia, Spain, 31Hospital Alfredo Espinosa, Urduliz, Pais Vasco, Spain, 32Hospital Obispo Polanco, Teruel, Spain, 33Hospital del Elda, Alicante, Spain, 34Hospital General Universitario Gregorio Marañón, Madrid, 35Hospital Los Arcos, Murcia, Spain, 36Hospital Marques de Valdecilla, Santander, Spain, 37Hospital Universitario Canarias, Tenerife, Spain, 38Hospital San Rafael, Barcelona, Spain, 39Hospital Universitario Nuestra Señora de la Candelaria, Santa Cruz de Tenerife, Spain, 40Hospital Severo Ochoa, Madrid, Spain, 41Instituto Provincial de Rehabilitación, Madrid, Spain, 42Hospital Virgen de la Arrixaca, Murcia, Spain, 43H. Virgen de Valme, Sevilla, Spain, 44Hospital El Escorial, Madrid, Spain, 45Hospital Infanta Leonor, Madrid, Spain, 46Hospital Universitario 12 de Octubre, Madrid, Spain, 47Hospital dos de Maig, Barcelona, Spain, 48Hospital Universitario Son Dureta, Palma de Mallorca, Spain, 49School of Medicine, University of Cantabria, and CIBER Epidemiología y Salud Pública (CIBERESP), Santander, Spain, 50Hospital Universitario Marques de Valdecilla, Santander, Cantabria, Spain

    Background/Purpose: To determine the incidence and risk factors implicated in the development of first cardiovascular (CV) event (CVE) in patients with chronic inflammatory rheumatic diseases…
  • Abstract Number: 1354 • ACR Convergence 2020

    The Effect of 8 Years of TNF-α Blocking Therapy on Bone Mineral Density in Patients with Ankylosing Spondylitis

    Mark Siderius1, Freke Wink1, Anneke Spoorenberg1 and Suzanne Arends1, 1University Medical Centre Groningen and Medical centre Leeuwarden, Groningen, Netherlands

    Background/Purpose: Ankylosing spondylitis (AS) is a chronic inflammatory disease that mainly affects the axial skeleton. Bone loss reflected by low bone mineral density (BMD) is…
  • Abstract Number: 1888 • ACR Convergence 2020

    Successful Evaluation of Spinal Mobility Measurements with the Epionics SPINE Device in Patients with Axial Spondyloarthritis Compared to Controls

    David Kiefer1, Xenofon Baraliakos2, Daniela Adolf3, Varvara Chatzistefanidi4, Ilka Schwarze5, Uwe Lange6, Jan Brandt-Jürgens7, Edgar Stemmler8, Sabine Sartingen8 and Juergen Braun9, 1Rheumazentrum Ruhrgebiet, Ruhr-University Bochum, Herne, Germany, 2Rheumazentrum Ruhrgebiet Herne, Ruhr-University Bochum, Bochum, Germany, 3StatConsult, Magdeburg, Germany, 4Rheumazentrum Ruhrgebiet Herne, Herne, 5Rheumazentrum Leipzig, Leipzig, 6Department of Rheumatology, Immunology, Osteology and Physical Medicine, Justus Liebig University Gießen, Campus Kerckhoff, Bad Nauheim, Germany, Bad Nauheim, Germany, 7Rheumatologische Schwerpunktpraxis Berlin, Berlin, Germany, 8AbbVie Deutschland GmbH & Co KG, Wiesbaden, Germany, 9Rheumazentrum Ruhrgebiet and Ruhr-University, 44649 Herne, Germany

    Background/Purpose: Axial spondyloarthritis (axSpA) comprising radiographic (r-) and non-radiographic (nr)-axSpA is often associated with loss of mobility and impaired physical function. Established assessments of spinal…
  • Abstract Number: 0553 • ACR Convergence 2020

    The US Prevalence of Ulcerative Colitis Associated Peripheral Arthralgias and Arthritis: Data from the National Health & Nutrition Examination Survey (NHANES)

    Oleg Stens1, Hyun-seok Kim2, Jason Hou2 and Michael Weisman3, 1Harbor-UCLA Medical Center, San Diego, CA, 2Baylor College of Medicine, Houston, TX, 3Cedars Sinai Medical Center, David Geffen School of Medicine at UCLA, Los Angeles, CA

    Background/Purpose: An association between ulcerative colitis (UC) and peripheral arthritis has been known since the 1930’s and more recently has been described as a part…
  • Abstract Number: 1370 • ACR Convergence 2020

    A Delayed Effect of Tumor Necrosis Factor Inhibitors on Radiographic Spinal Progression in Patients with Axial Spondyloarthritis: Long-term Results from the German Spondyloarthritis Inception Cohort

    Denis Poddubnyy1, Valeria Rios Rodriguez2, Murat Torgutalp2, Ani Dilbaryan2, Maryna Verba2, Mikhail Protopopov2, Fabian Proft2, Judith Rademacher2, Hildrun Haibel2, Joachim Sieper2 and Martin Rudwaleit3, 1Charité – Universitätsmedizin Berlin, Berlin, Germany, 2Charité Universitätsmedizin Berlin, Berlin, Germany, 3Department of Internal Medicine and Rheumatology, Klinikum Bielefeld, Germany

    Background/Purpose: There are inconclusive data on the effect of tumor necrosis factor inhibitors (TNFi) on radiographic spinal progression in axial spondyloarthritis (axSpA). Although inflammation and…
  • Abstract Number: 2013 • ACR Convergence 2020

    Substantial Lifetime Risk of Developing Ankylosing Spondylitis (Axial Spondyloarthritis) for Relatives. Evidence from a 35-Year Follow-up Family Study of a Swiss Cohort

    Sjef van der Linden1, Peter Villiger2, Zhixiu Li3, Matthew Brown4, Heinz Baumberger5, Hermine Zandwijk6 and Muhammad Khan7, 1Department of Rheumatology, Immunology and Allergology, University of Bern, Inselspital, Bern, Switzerland, Mortroux, Belgium, 2Department of Rheumatology, Immunology and Allergology, University of Bern, Inselspital, Switzerland, Bern, Switzerland, 3Queensland University of Technology (QUT), Translational Genomics Group, School of Biomedical Sciences, Institute of Health and Biomedical Innovation, Translational Research Institute, Princess Alexandra Hospital, Brisbane, Qld, Australia, Brisbane, Queensland, Australia, 4Guy's and St Thomas, NHS Foundation Trust and King's College London NIHR Biomedical Research Centre, King's College London, London, United Kingdom, London, United Kingdom, 5Retired, Flims, Tajikistan, 6Retired, Mortroux, Belgium, 7Case Western Reserve University, Cleveland OH, Westlake, OH

    Background/Purpose: Familial occurrence of ankylosing spondylitis (AS) is well known. Our follow-up study aimed at assessing the incidence of clinically defined AS among first degree…
  • Abstract Number: 0897 • ACR Convergence 2020

    Temporal Achievement of Clinical Response and Inactive Disease Status in Patients with Axial Spondyloarthritis Treated with Etanercept

    Xenofon Baraliakos1, Annette Szumski2, Kenneth Kwok3 and Bonnie Vlahos4, 1Rheumazentrum Ruhrgebiet Herne, Ruhr-University Bochum, Bochum, Germany, 2Syneos Health, Princeton, 3Pfizer, New York, NY, 4Pfizer, Collegeville, PA

    Background/Purpose: Treatment with etanercept (ETN) is effective and well tolerated in patients with axial spondyloarthritis (AS), but the time frames within which patients tend to…
  • Abstract Number: 1376 • ACR Convergence 2020

    Impact of Body Composition Measures on the Response to Biological Disease-modifying Anti-rheumatic Drugs in Patients with Ankylosing Spondylitis

    Valeria Rios Rodriguez1, Mikhail Protopopov1, Fabian Proft1, Judith Rademacher1, Burkhard Muche1, Anne-Katrin Weber1, Susanne Lüders1, Hildrun Haibel1, Maryna Verba1, Joachim Sieper1 and Denis Poddubnyy2, 1Charité Universitätsmedizin Berlin, Berlin, Germany, 2Charité – Universitätsmedizin Berlin, Berlin, Germany

    Background/Purpose: Data on the impact of body weight and body mass index (BMI) on the response to biological disease-modifying anti-rheumatic drugs (bDMARDs) in axial spondyloarthritis…
  • Abstract Number: 2014 • ACR Convergence 2020

    The Relative Diagnostic Utility of Inflammatory Back Pain Criteria in an Inception Cohort of Patients with Psoriasis, Iritis, and Colitis Presenting with Undiagnosed Back Pain

    Georg Kröber1, Ulrich Weber2, Raj Carmona3, James Yeung4, Jon Chan5, Sibel Aydin6, Liam Martin7, Ariel Masetto8, Stephanie Keeling9, Olga Ziouzina7, Sherry Rohekar10, Rana Dadashova11, Joel Paschke11, Amanda Carapellucci11, Robert G Lambert12 and Walter Maksymowych9, 1University of Southern Denmark, Sønderborg, Denmark, 2University of South Denmark, Odense, Denmark, 3St. Joseph's Healthcare, Hamilton, ON, Canada, 4James Yeung Rheumatology, Vancouver, BC, Canada, 5Artus Health Clinic, Vancouver, BC, Canada, 6University of Ottawa Faculty of Medicine, Rheumatology, Ottawa, ON, CANADA; The Ottawa Hospital Research Institute, Ottawa, ON, CANADA, Ottawa, ON, Canada, 7University of Calgary, Calgary, AB, Canada, 8University of Sherbrooke, Sherbrooke, QC, Canada, 9University of Alberta, Edmonton, AB, Canada, 10Lawson Health Research Institute, London, ON, Canada, 11CARE Arthritis, Edmonton, AB, Canada, 12University of Alberta and CARE Arthritis, Edmonton, AB, Canada

    Background/Purpose: Patients with psoriasis, iritis, or colitis and back pain represent a high-risk population for the presence of axial spondyloarthritis (axSpA). Clinicians rely on the…
  • Abstract Number: 1202 • ACR Convergence 2020

    Cannabis Use Assessment and Its Impact on Pain in Rheumatic Diseases: A Systematic Review and Meta-analysis

    Manon Guillouard1, Nicolas Authier1, Bruno Pereira1, Martin Soubrier1 and Sylvain Mathieu1, 1CHU Gabriel Montpied, Clermont-Ferrand, France

    Background/Purpose: Despite classic analgesic or effective treatments in rheumatic diseases, such as synthetic Disease Modifying Anti-Rheumatic Drugs in rheumatoid arthritis (RA), patients remain in pain…
  • Abstract Number: 1498 • ACR Convergence 2020

    Pregnancy Outcomes in Patients with Axial Spondyloarthritis – a First Analysis of a European Collaboration of Pregnancy Registries

    Yvette Meissner1, Nathalie Costedoat-Chalumeau2, Frauke Foerger3, Doreen Goll4, Anna Molto5, Rebecca Özdemir6, Marianne Wallenius7, Anja Strangfeld8 and Rebecca Fischer-Betz9, 1Deutsches Rheuma-Forschungszentrum, Berlin, Germany, 2APHP, Université de Paris, Paris, France, 3University Hospital and University of Bern, Bern, Switzerland, Bern, Switzerland, 4Patient Research Partner, Berlin, Germany, 5Rheumatology Department, Cochin Hospital, Paris, Paris, France, 6Patient Research Partner, Duisburg, Germany, 7University Hospital and Norwegian University of Science and Technology, Trondheim, Norway, 8German Rheumatism Research Center, Berlin, Germany, 9Department of Rheumatology and Hiller Research Unit Rheumatology, Heinrich Heine University, Duesseldorf, Germany, Duesseldorf, Germany

    Background/Purpose: Axial spondyloarthritis (axSpA) can affect women in their childbearing age. Data on pregnancy in axSpA patients are mainly retrospective and highly heterogeneous [1]. The…
  • Abstract Number: 2018 • ACR Convergence 2020

    Development and Validation of an Artificial Intelligence Approach for the Detection of Radiographic Sacroiliitis

    Keno-Kyrill Bressem1, Janis Vahldiek1, Lisa Adams1, Stefan Niehues1, Hildrun Haibel1, Valeria Rios Rodriguez1, Murat Torgutalp1, Mikhail Protopopov1, Fabian Proft1, Judith Rademacher1, Joachim Sieper1, Martin Rudwaleit2, Bernd Hamm1, Markus Makowski1, Kay-Geert Hermann1 and Denis Poddubnyy3, 1Charité Universitätsmedizin Berlin, Berlin, Germany, 2Department of Internal Medicine and Rheumatology, Klinikum Bielefeld, Germany, 3Charité – Universitätsmedizin Berlin, Berlin, Germany

    Background/Purpose: Conventional radiography of the sacroiliac joints is still recommended as the first imaging method if axial spondyloarthritis (axSpA) is suspected. Furthermore, radiographic sacroiliitis is…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology